- A medicament characterized by a novel component.
- A medicament characterized by a novel composition.
- A medicament characterized by a novel use.
The expert committee recommends that the following category of invention become a patentable subject matter as well.
- A medicament characterized by a novel dose (amount per administration) and a novel usage (dosage interval).
A medicament sold with indications for the dose and usage will infringe the corresponding patent. A medicament without indication will not.
The committee suggests that such a medicament characterized by novel dose and usage be considered to involve inventive steps only when it should dramatically reduce the side effect or improve patients' quality of life (QOL).
No comments:
Post a Comment